Although rFc-μTP-L309C was shown to inhibit neutrophil infiltration into the joint as well as IL-1β, and this effect was undoubtedly responsible, at least in part, for the amelioration of the severe arthritis in these mice, it didn’t provide a complete understanding of possible mechanisms for the therapeutic response of the molecule. This evidence concerns the gene IL1B and arthritic joint disease.